Skin troubles from breast cancer treatment: a hidden burden on daily life

NCT ID NCT06690489

Completed Knowledge-focused Sponsor: Pierre Fabre Medicament Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study involved 155 women with early breast cancer who had been taking hormone therapy for 2-3 years. Researchers wanted to understand how skin-related side effects from the treatment impact their quality of life. Participants filled out questionnaires about their skin symptoms and how they affected their daily activities and emotions. The goal was to measure the real-world burden of these skin issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EARLY BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EARLY BREAST CANCER QUALITY OF LIFE SKIN CONDITION

Contacts and locations

Show contact details

Locations

Aristotle University of Thessaloniki

Thessaloniki, Greece
Clinica Dermatologica dell'Università di Napoli "Federico II"

Naples, Italy
Fondazione Policlinico A. Gemelli

Roma, Italy
Hospital Del Mar

Barcelona, Spain
Hospital General de Fuerteventura

Las Palmas, Spain
Institut Universitaire du Cancer Toulouse - Oncopole

Toulouse, 31100, France
Institut du Cancer de Montpellier - Val d'Aurelle

Montpellier, France
Sant'Orsola-Malpighi Hospital University of Bologna

Bologna, Italy
Sygros Hospital

Athens, Greece

More trials for these conditions

Other studies related to the condition(s) this trial covers.